Gender difference in the utilization and users' characteristics of community rehabilitation programs for cerebrovascular disease patients in Japan

International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
N TamiyaEiji Yano

Abstract

The purpose of this study was to see whether there was gender difference in the utilization of a community rehabilitation program for cerebrovascular disease (CVD) patients in Japan and to examine factors affecting this gender difference. For CVD patients who participated in 16 community rehabilitation programs in the Saitama prefecture (n = 190), we studied their clinical and functional status, socioeconomic conditions, the degree of family support, and their use of rehabilitation and transportation services. The general characteristics of the programs and the type of transportation services they offered were also surveyed. The female proportion of all the program participants was 34.2% and its proportion tended to be smaller when their ADL level was worse. However, such difference by gender lessened after the participants were stratified by the type of transportation services and by such conditions as being accompanied by a family member during transportation.

Citations

Aug 31, 2002·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Nanako TamiyaEiji Yano
Jul 16, 2008·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Nanako Tamiya
Mar 16, 2013·The International Journal of Health Planning and Management·Dohyeong KimDale Whittington

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.